Reid ME,Toy PT. Simplified method for recovery of autologous red blood cells from transfused patients. Am J Clin Pathol 1983;79:364-6.10.1093/ajcp/79.3.3646829505Search in Google Scholar
Brown DJ. A rapid method for harvesting autologous red cells from patients with hemoglobin S disease. Transfusion 1988;28:21-3.10.1046/j.1537-2995.1988.28188127945.x3341060Search in Google Scholar
Laine EP, Leger RM,Arndt PA,et al.In vitro studies on the impact of transfusion on the detection of alloantibodies after autoadsorption. Transfusion 2000;40:1384-7.10.1046/j.1537-2995.2000.40111384.x11099669Search in Google Scholar
Allogeneic red cell adsorption for removal of warm autoantibody. In: Immunohematology methods and procedures. 1st ed. The American National Red Cross 1993:47-51.Search in Google Scholar
Liew YW, Duncan N. Polyethylene glycol in autoadsorption of serum for the detection of alloantibodies (letter).Transfusion 1995;35:713.10.1046/j.1537-2995.1995.35895357907.x7631416Search in Google Scholar
Chiaroni J,Touinssi M, Mazet M, deMicco P,Ferrera V. Adsorption of autoantibodies in the presence of LISS to detect alloantibodies underlying warm autoantibodies. Transfusion 2003;43:651-5.10.1046/j.1537-2995.2003.00356.x12702189Search in Google Scholar
Barron CL, Brown MB. The use of polyethylene glycol (PEG) to enhance the adsorption of autoantibodies. Immunohematology 1997;13:119-22.10.21307/immunohematology-2019-726Search in Google Scholar
Judd WJ, Dake L.PEG adsorption of autoantibodies causes loss of concomitant alloantibody. Immunohematology 2001;17:82-5.10.21307/immunohematology-2019-552Search in Google Scholar
Leger RM, Garratty G. Evaluation of methods for detecting alloantibodies underlying warm autoanti-bodies. Transfusion 1999;39:11-6.10.1046/j.1537-2995.1999.39199116889.x9920161Search in Google Scholar
Branch DR, Petz LD. Detecting alloantibodies in patients with autoantibodies (editorial). Transfusion 1999;39:6-10.10.1046/j.1537-2995.1999.39199116888.x9920160Search in Google Scholar
Cheng C-K,Wong ML, Lee AW. PEG adsorption of autoantibodies and detection of alloantibodies in warm autoimmune hemolytic anemia. Transfusion 2001;41:13-7.10.1046/j.1537-2995.2001.41010013.x11161239Search in Google Scholar
Leger RM, Ciesielski D,Garratty G.Effect of storage on antibody reactivity after adsorption in the presence of polyethylene glycol (letter). Transfusion 1999;39:1272-3.10.1046/j.1537-2995.1999.39111272.x10604258Search in Google Scholar
Storry JR, Mallory D. Misidentification of anti-Vel due to inappropriate use of prewarming and adsorption techniques. Immunohematology 1994; 10:83-6.10.21307/immunohematology-2019-927Search in Google Scholar
Judd WJ. Controversies in transfusion medicine. Prewarmed techniques:Con. Transfusion 1995;35: 271-5.10.1046/j.1537-2995.1995.35395184287.x7878723Search in Google Scholar
Mallory D. Controversies in transfusion medicine. Prewarmed tests: Pro—why, when, and how—not if. Transfusion 1995;35:268-70.10.1046/j.1537-2995.1995.35395184286.x7878722Search in Google Scholar
Garratty G. Attack on prewarmed tests—Too much hot air (letter)? Transfusion 1996;36:192.10.1046/j.1537-2995.1996.36296181936.x8614974Search in Google Scholar
Judd WJ, Steiner EA, Knaff P, Davenport RD. Failure to detect potentially significant antibodies in prewarmed tests (abstract). Transfusion 1995;35: (Suppl):68S.Search in Google Scholar
Kilsby MA.Comparison of prewarmed techniques: with and without enhancements (abstract). Transfusion 1999;39(Suppl):104S.Search in Google Scholar
Leger RM, Garratty G. Weakening or loss of antibody reactivity after prewarm technique. Transfusion 2003;43:1611-4.10.1046/j.1537-2995.2003.00563.x14617322Search in Google Scholar
Petz LD, Garratty G. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004: 133-65,352-6.10.1016/B978-0-443-08559-8.50008-XSearch in Google Scholar
Reid M, Lomas-Francis C.The blood group antigen factsbook. 2nd ed. San Diego: Elsevier Academic Press, 2004.10.1016/B978-012586585-2/50007-XSearch in Google Scholar
Issitt PD,Anstee DJ. Applied blood group serology. 4th ed. Durham:Montgomery 1998.Search in Google Scholar
Daniels G. Human blood groups. 2nd ed. Oxford: Blackwell Science, 2002.10.1002/9780470987018Search in Google Scholar
Garratty G. Evaluating the clinical significance of blood group alloantibodies that are causing problems in pretransfusion testing. Vox Sang 1998; 74:285-90.10.1111/j.1423-0410.1998.tb05433.x9704458Search in Google Scholar
Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004 (in press).10.1111/j.1537-2995.2004.03427.x15318848Search in Google Scholar
Daniels G, Poole J,de Silva M,et al. The clinical significance of blood group antibodies. Transfus Med 2002;12:287-95.10.1046/j.1365-3148.2002.00399.xSearch in Google Scholar
Leger RM. In vitro cellular assays and other approaches used to predict the clinical significance of red cell alloantibodies: a review. Immunohematology 2002;18:65-70.10.21307/immunohematology-2019-512Search in Google Scholar
Reid ME, Øyen R, Marsh WL. Summary of the clinical significance of blood group alloantibodies. Semin Hematol 2000;37:197-216.10.1016/S0037-1963(00)90044-1Search in Google Scholar
Nance S. Review: measuring red cell survival and determining the clinical significance of red cell antibodies. Immunohematology 1995;11:31-8.10.21307/immunohematology-2019-784Search in Google Scholar
Engelfriet CP, Overbeeke MAM, Dooren MC, Ouwehand WH, von dem Borne AEGKr. Bioassays to determine the clinical significance of red cell alloantibodies based on Fc receptor-induced destruction of red cells sensitized by IgG. Transfusion 1994;34:617-26.10.1046/j.1537-2995.1994.34794330018.xSearch in Google Scholar
Garratty G. Factors affecting the pathogenicity of red cell auto- and alloantibodies. In:Nance SJ, ed. Immune destruction of red blood cells. Arlington, VA: American Association of Blood Banks, 1989; 109-69.Search in Google Scholar
Garratty G. Predicting the clinical significance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, eds. Clinical and serological aspects of transfusion reactions: a technical workshop. Washington DC: American Association of Blood Banks, 1982: 91-119.Search in Google Scholar
Engelfriet CP, Ouwehand WH. ADCC and other cellular bioassays for predicting the clinical significance of red cell alloantibodies. Baillieres Clin Haematol 1990;3:321-37.10.1016/S0950-3536(05)80053-8Search in Google Scholar
Hadley A, Wilkes A, Poole J, Arndt P, Garratty G. A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med 1999;9:337-42.10.1046/j.1365-3148.1999.00218.x10583888Search in Google Scholar
Schanfield MS, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay.Transfusion 1981;21:571-6.10.1046/j.1537-2995.1981.21582040822.x6794195Search in Google Scholar
Branch DR, Gallagher MT, Mison AP,Sy Siok Hian AL, Petz LD. In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes.Br J Haematol 1984;56:19-29.10.1111/j.1365-2141.1984.tb01268.x6704325Search in Google Scholar
Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27: 449-52.10.1046/j.1537-2995.1987.27688071692.x3686653Search in Google Scholar
Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. T.ransfus Med Rev 1990;IV:297-312.10.1016/S0887-7963(90)70272-6Search in Google Scholar
Zupan’ska B, Gronkowska A, Ziemski M. Comparison of activity of peripheral monocytes and splenic macrophages in the monocyte monolayer assay.Vox Sang 1995;68:241-2.10.1111/j.1423-0410.1995.tb02580.x7660644Search in Google Scholar
Nance SJ,Arndt PA, Garratty G.The effect of fresh normal serum on monocyte monolayer assay reactivity.Transfusion 1988;28:398-9.10.1046/j.1537-2995.1988.28488265281.x3388490Search in Google Scholar
Church A, Mallory D, Kavitsky D, Nance S. Impact of complement in the monocyte monolayer assay (abstract).Transfusion 1997;37(Suppl):27S.Search in Google Scholar
Branch DR,Gallagher MT. The importance of CO2 in short-term monocyte-macrophage assays (letter).Transfusion 1985;25:399.10.1046/j.1537-2995.1985.25485273829.x3927533Search in Google Scholar
AuBuchon JP,Brightman A,Anderson HJ, Kim B.An example of anti-Yta demonstrating a change in its clinical significance.Vox Sang 1988;55:171-5.Search in Google Scholar
DiNapoli J, Gingras A, Diggs E, Alicea-Tossas E, Kessler L. Survival of Ge+ red cells in a patient with anti-Ge1,2: data from51Cr, flow cytometric, IgG subclass, and monocyte erythrophagocytosis assays (abstract). Transfusion 1986;26:545.Search in Google Scholar
Anderson G, Gray LS, Mintz PD. Red cell survival studies with a patient with anti-Tca. Am J Clin Pathol 1991;95:87-90.10.1093/ajcp/95.1.871987756Search in Google Scholar
Nance S, Scandone P, Fassl L,et al. Monocyte monolayer assay (MMA) results are affected by transfusion of incompatible red cells (abstract). Transfusion 1997;37(Suppl):37S.Search in Google Scholar
Kakaiya R, Sheahan E, Julleis J,et al.51Chromium studies with an IgG1 anti-Yta (letter). Immunohematology 1991;7:107.Search in Google Scholar
Pearson HA, Richards VL, Wylie BR, et al. Assessment of clinical significance of anti-Ge in an untransfused man. Transfusion 1991;31:257-9.10.1046/j.1537-2995.1991.31391165177.x2003326Search in Google Scholar
Issitt PD, Gutgsell NS, Hervis L. Some stored antibodies give unreliable results in the monocyte monolayer assay (letter). Transfusion 1988;28: 399-400.10.1046/j.1537-2995.1988.28488265282.x3388491Search in Google Scholar
Wren MR, Issitt PD. The monocyte monolayer assay and in vivo antibody activity (abstract). Transfusion 1986;26:548.Search in Google Scholar
Gibson M, Devenish A, Daniels GL, Contreras M. A transfusion problem in a thalassaemic infant with anti-Lu6 (abstract). Ann Mtg Br Blood Transfus Soc 1983;27.Search in Google Scholar
Issitt PD, Valinsky JE, Marsh WL, DiNapoli J, Gutgsell NS. In vivo red cell destruction by anti- Lu6.Transfusion 1990;30:258-60.10.1046/j.1537-2995.1990.30390194349.x2316000Search in Google Scholar
Yahalom V, Ellis MH, Poole J,et al. The rare Lu:-6 phenotype in Israel and the clinical significance of anti-Lu6.Transfusion 2002;42:247-50.10.1046/j.1537-2995.2002.00019.x11896342Search in Google Scholar
Shirey RS, Øyen R, Heeb KN, Kickler TS, Ness PM.51Cr radiolabeled survival studies in a patient with anti-Lu12 (abstract). Transfusion 1988;28(Suppl): 37S.Search in Google Scholar
McSwain B, Robins C.A clinically significant anti- Cra (letter). Transfusion 1988;28:289-90.10.1046/j.1537-2995.1988.28388219165.x3368942Search in Google Scholar
Leatherbarrow MB, Ellisor SS, Collins PA,et al. Assessing the clinical significance of anti-Cra and anti-M in a chronically transfused sickle cell patient. Immunohematology 1988;4:71-4.10.21307/immunohematology-2019-1108Search in Google Scholar
Bell JA, Johnson ST, Moulds M,et al. Clinical significance of anti-Tcab in the second example of a Tc(a–b–) individual (abstract). Transfusion 1989;29 (Suppl):17S.Search in Google Scholar
Judd WJ, Oberman HA, Silenieks A, Steiner EA. Clinical significance of anti-Lan (letter). Transfusion 1984;24:181.10.1046/j.1537-2995.1984.24284173358.x6585080Search in Google Scholar
Ramsey G,Sherman LA, Zimmer AM,et al. Clinical significance of anti-Ata.Vox Sang 1995;69:135-7.10.1111/j.1423-0410.1995.tb01684.x8585195Search in Google Scholar
Sweeney JD, Holme S, McCall L,et al. At(a–) phenotype: description of a family and reduced survival of At(a+) red cells in a proposita with anti- Ata. Transfusion 1995;35:63-7.10.1046/j.1537-2995.1995.35195090666.x7998074Search in Google Scholar
Baldwin ML, Ness PM, Barrasso C,et al. In vivo studies of the long-term51Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34-8.10.1046/j.1537-2995.1985.25185116499.x3969699Search in Google Scholar
Morel PA, Hamilton HB. Oka: an erythrocytic antigen of high frequency.Vox Sang 1979;36:182-5.Search in Google Scholar
Gutgsell NS, Issitt LA, Issitt PD. Transfusion of antigen-positive, serologically-incompatible blood in immunized patients, based solely on the results of a monocyte monolayer assay (MMA) (abstract). Transfusion 1988;28:32S.10.1046/j.1537-2995.1988.28488265282.x3388491Search in Google Scholar
Eckrich RJ,Mallory DM, Sandler SG. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti- Yta. Immunohematology 1995;11:81-4.10.21307/immunohematology-2019-795Search in Google Scholar
Zupanska B, Brojer E, McIntosh J, Seyfried H, Howell P. Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D.Vox Sang 1990;58:276-80.10.1111/j.1423-0410.1990.tb04999.x2399692Search in Google Scholar
Hildebrandt M, Hell A, Etzel R, Genth R, Salama A. Determination and successful transfusion of anti- Gerbich-positive red blood cells in a patient with a strongly reactive anti-Gerbich antibody. Infusionsther Transfusionsmed 2000;27:154-6.10.1159/00002526110878485Search in Google Scholar
Chapman RL, Hare V. Successful repeated transfusion of Cr(a+) blood to a patient with anti-Cra (abstract). Transfusion 1992;32:23S.10.1046/j.1537-2995.1992.32492263457.x1585447Search in Google Scholar
Byrne PC, Eckrich RJ, Malamut DC, Mallory DM, Sandler SG. Use of the monocyte monolayer assay (MMA) to predict the clinical significance of anti- Cra (abstract). Transfusion 1995;35:61S.Search in Google Scholar
Kowalski MA, Pierce SR, Edwards RL, et al. Hemolytic transfusion reaction due to anti-Tca. Transfusion 1999;39:948-50.10.1046/j.1537-2995.1999.39090948.x10533820Search in Google Scholar
Kobuszewski M, Wallace M, Moulds M, et al. Clinical significance of anti-Lu8 in a patient who received Lu:8 red cells (abstract). Transfusion 1988;28(Suppl):37S.Search in Google Scholar
Bacon J, Sherrin D,Wright RG. Case report,anti-Jra (letter).Transfusion 1986;26:543-4.10.1046/j.1537-2995.1986.26687043624.x3775839Search in Google Scholar
Kwon MY,Su L, Arndt PA, Garratty G, Blackall DP. Clinical significance of anti-Jra: report of two cases and review of the literature. Transfusion 2004;44: 197-201.10.1111/j.1537-2995.2004.00643.x14962310Search in Google Scholar
Leger R, Arndt P,Co A, O’Brien L, Garratty G. Clinical significance of an anti-Dib assessed by flow cytometry. Immunohematology 1997;13: 93-6.10.21307/immunohematology-2019-715Search in Google Scholar
Nakache R, Levene C, Sela R, Kaufman S, Shapira Z. Dra (Cromer-related blood group antigen)- incompatible renal transplantation. Vox Sang 1998;74:106-8.10.1046/j.1423-0410.1998.7420106.xSearch in Google Scholar
Daniels GL, Judd WJ, Moore BPL, et al.A ‘new’ high frequency antigen Era. Transfusion 1982;22: 189-93.10.1046/j.1537-2995.1982.22382224938.x7090030Search in Google Scholar
International Committee for Standardization in Haematology. Recommended method for radioisotope red-cell survival studies. Br J Haematol 1980;45:659-66.10.1111/j.1365-2141.1980.tb07189.x7426443Search in Google Scholar
